Novator Pharma
Novator Pharma is a dynamically developing international pharmaceutical company founded in 2007 in the UK with headquarters in London. The main activity is the development and launch of unique combinations of known components to the pharmaceutical market. The company aims to provide a decent quality of life for modern people around the world and holds a top ten position in all markets of promotion. It operates in the United Kingdom, Russia, Kazakhstan, Ukraine, Azerbaijan, and other countries.
Industries
Nr. of Employees
medium (51-250)
Products
Denaf
Rectal suppositories containing diclofenac sodium 100 mg with dosing and contraindication information.
Chondrocsil
Oral tablets containing glucosamine sulfate, chondroitin sulfate and methylsulfonylmethane for degenerative joint conditions.
Diplas
Nasal spray formulation containing sodium hyaluronate, vitamin C and botanical extracts for nasal mucosa hydration and symptomatic care.
Brocsevin
Expectorant syrup formulation containing N‑acetylcysteine and botanical extracts for symptomatic therapy of respiratory conditions with viscous secretions.
Fulmex
Oral antifungal capsules containing fluconazole 150 mg for treatment of mucosal, cutaneous and systemic fungal infections.
Dornax
Oral bisphosphonate tablets containing alendronic acid 70 mg indicated for treatment and prevention of osteoporosis.
Denaf
Rectal suppositories containing diclofenac sodium 100 mg with dosing and contraindication information.
Chondrocsil
Oral tablets containing glucosamine sulfate, chondroitin sulfate and methylsulfonylmethane for degenerative joint conditions.
Diplas
Nasal spray formulation containing sodium hyaluronate, vitamin C and botanical extracts for nasal mucosa hydration and symptomatic care.
Brocsevin
Expectorant syrup formulation containing N‑acetylcysteine and botanical extracts for symptomatic therapy of respiratory conditions with viscous secretions.
Fulmex
Oral antifungal capsules containing fluconazole 150 mg for treatment of mucosal, cutaneous and systemic fungal infections.
Dornax
Oral bisphosphonate tablets containing alendronic acid 70 mg indicated for treatment and prevention of osteoporosis.
Services
Development of finished pharmaceutical formulations and product information for a range of dosage forms and therapeutic areas.
Coordination of international partnerships and distribution relationships to place pharmaceutical products into multiple country markets.
Development of finished pharmaceutical formulations and product information for a range of dosage forms and therapeutic areas.
Coordination of international partnerships and distribution relationships to place pharmaceutical products into multiple country markets.
Expertise Areas
- Pharmaceutical formulation development
- Dosage form development (oral, topical, nasal, rectal, parenteral)
- Parenteral/IV formulation development and compatibility
- Pediatric formulation development
Key Technologies
- Oral solid dosage formulation
- Liquid (syrup) formulation
- Topical gel formulation
- Nasal spray formulation